Tang, X., Jian, J., Guo, Y., Zhao, L., An, S., Liu, B. (2025). Efficacy and safety of azacitidine plus low-dose dasatinib maintenance therapy for patients with intermediate and high-risk acute myeloid leukemia: A prospective, randomized, phase Ⅱ clinical trial. Blood. https://doi.org/10.1182/blood-2025-1002